Guidelines on urology care during the COVID-19 pandemic (search done on 17 April 2020)
Citation: Heldwein FL, Loeb S, Wroclawski ML, et al. A Systematic Review on Guidelines and Recommendations for Urology Standard of Care During the COVID-19 Pandemic. European Urology Focus. 2020 Sep 15;6(5):1070-85.
What is this? The COVID-19 pandemic is placing a strain on healthcare systems leading to changes in how patients with other conditions are managed. Guidelines have been produced for the management of patients with existing urological conditions.
In this rapid review, the authors searched for guidelines on urology standards of care published during the COVID-19 pandemic. They restricted their searches to guidelines published in English between November 2019 and 17 April 2020. They identified 15 guidelines from Australia and New Zealand, Brazil, Canada, Europe, and the USA, and noted that the quality of the evidence was low to moderate.
What was found: At the time of this review, the included guidelines recommended active surveillance for lower risk tumours such as low risk prostate cancer, low-grade bladder cancer, and small renal masses.
At the time of this review, the included guidelines indicated that omission of systemic therapies or cytoreductive nephrectomy should be considered in some advanced cases.
At the time of this review, the included guidelines showed that treatment of non-obstructed renal stones could be delayed for months, but that infection or obstruction should be treated as an emergency.
At the time of this review, the included guidelines recommended that aerosol generating procedures should be avoided during surgery.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.